Production of recombinant human interferon-beta2
AssigneeYeda Research and Development Co. Ltd.
InventorsMichel Revel, Pierre Tiollais
Life of this patent
Estimating the term…
Abstract
Human interferon-beta.sub.2.sbsb.A and interferon-beta.sub.2.sbsb.B are produced in purified form by recombinant DNA techniques. Two separate human genes have been identified which code for the production of IFN-.beta..sub.2.sbsb.A and IFN-.beta..sub.2.sbsb.B, respectively. The sequence of IFN-.beta..sub.2.sbsb.A cDNA is established. These genes and cDNA have been cloned into mammalian cells with an SV40 early promoter sequence and such genomic clones are capable of producing IFN-.beta..sub.2.sbsb.A and IFN-.beta..sub.2.sbsb.B. The antiviral activity of such recombinant IFN-.beta..sub.2.sbsb.A and IFN-.beta..sub.2.sbsb.B is demonstrated as well as other biological activity identifying them as human interferons.
Claims3
A DNA molecule including a portion of the DNA which codes for IFN-.beta..sub.2A, which DNA molecule is capable of hybridizing to mRNA encoding human IFN-.beta..sub.2A in 50% formamide at 52.degree..
Isolated DNA which, codes for IFN-.beta..sub.2A.
Dependencies are inferred from the claim text.